Many viruses are associated with erythema (1) . It is difficult to differentiate causative viruses based on clinical symptoms alone. We investigated the presence of 5 viruses associated with rashes-measles virus [MV] , rubella virus [RV] , human parvovirus B19 [PVB19], human herpes virus 6 , and HHV-7-in clinical specimens from patients with erythema. Simultaneous detection of the viruses was performed using multiplex real-time PCR to reduce the detection time.
From January 2006 to December 2011, 187 clinical specimens (123 throat swabs, 29 serum samples, 26 nasal mucus samples, 4 whole blood samples, 2 urine samples, 2 mouth wash samples, and 1 conjunctival swab) were collected from 169 patients with erythema as part of a virus surveillance program in Osaka City, Japan (2) . There were 92 men and 77 women patients aged 0 to 450 months (mean 48.0 ± 71.7 standard deviation). Peripheral blood mononuclear cells were separated from whole blood specimens using Mono-Poly Resolving Medium (DS Pharma Biomedical Co., Osaka, Japan) and were used in the subsequent tests. RNA and DNA were extracted simultaneously using a QIAamp Viral RNA Mini kit (QIAGEN Inc., Valencia, Calif., USA) (3) and cDNA was synthesized using the PrimeScript RT reagent kit (Takara Bio Inc., Shiga, Japan). Multiplex real-time PCR detection of 5 viruses (MV, RV, PVB19, HHV-6, and HHV-7) was performed using the QuantiTect Multiplex PCR kit (QIAGEN), according to the manufacturer's instructions. Sequence information for primers, TaqMan probes, and their combinations for target viruses are shown in Table 1 . MV, RV, and PVB19 were detected simultaneously in a single well as Set 1, and HHV-6 and HHV-7 were detected in another single well as Set 2 (Table 1) . Previously reported primers and probes were modified for the detection of RV, PVB19, HHV-6, and HHV-7 (4-6). Primers and probes for the detection of MV were designed for this study. The presence of HHV-6 and HHV-7 was only investigated in serum samples. The PCR conditions were as follows: 959 C for 15 min, followed by 45 cycles at 949 C for 60 s, and 609 C for 90 s, using a 7500 RealTime PCR System (Life Technologies Corp., Carlsbad, Calif., USA).
The results showed that 41 specimens (21.9z) from a total of 37 patients tested positive for virus (Table 2) as follows: MV (n ＝ 23), PVB19 (n ＝ 8), RV (n ＝ 2), HHV-6 (n ＝ 5), HHV-7 (n ＝ 1), MV and PVB19 (n ＝ 1), and HHV-6 and HHV-7 (n ＝ 1). Epidemiological data suggests that 3 of the 8 PVB19-positive specimens were from 2 patients (2-year-and 4-year-old sisters) in the same family. Two MV-positive specimens were determined to be from brothers (aged 2 years and 5 years). The other virus-positive specimens were all from sporadic cases. Results of multiplex real-time PCR for MV were compared to those for RT-PCR of the hemagglutinin gene (7) and showed 100z sensitivity and 98.8z specificity (data not shown). All the MV-positive cases were detected in 2007 and the strains (21/24, 87.5z) whose sequence were available were demonstrated to be of genotype D5 based on the phylogenetic analysis of the nucleoprotein gene (7, 8) . The Western Pacific Regional Office of the World Health Organization planned to eliminate measles by 2012 from 37 countries and areas of the Western Pacific Region, including Japan (9) . To determine the accurate number of MVpositive patients, it is important to be able to differentiate MV from other rash-associated viruses. Detection of HHV-6 and HHV-7 DNA are not always associated with a rash as both viruses cause persistent infections (10) . Moreover, IgM and IgG tests for HHV-6 and HHV-7 were not done. Therefore, it is unclear whether detection of HHV-6 and HHV-7 DNA is directly associated with rash in this study. The results of this study indicate that the multiplex real-time PCR might be a useful screening method for the detection and differentiation of rash-associated viruses in clinical specimens. However, the detection rate was low (11.0z, 18/164) when MV-positive specimens were excluded, and testing for other rash-associated viruses, such as enterovirus, should also be included. Further examination and analysis are needed to evaluate this assay system.
